RSV Corporation

Astellas Pharma Inc. views prostate cancer therapy Xtandi (enzalutamide) as a growth driver as it reorganizes its R&D structure to encourage innovation in oncology. In a Feb. 3 earnings call, Aste

IN VITRO DIAGNOSTICS Alliances NovaMedica LLC Venter Pharma SL Russian specialty pharmaco NovaMedica LLC received exclusive rights to commercialize Spanish firm Venter Pharma SL ’s lactose into

Astellas Pharma Inc. views prostate cancer therapy Xtandi (enzalutamide) as a growth driver as it reorganizes its R&D structure to encourage innovation in oncology. In a Feb. 3 earnings call, Aste

Astellas Pharma Inc. has had minor involvement with vaccines in recent years. But in late 2013, the firm in-licensed worldwide rights for Mymetics Corp. ’s preclinical respiratory syncytial virus